Home
LM Funding
Approach
LM Funding Products
Investors
Blog
Career Opportunities
Referral Program
Contact
No menu assigned!
All SEC Filings
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
DEF 14A
DEF 14C
DEFA14A
DRS
EFFECT
NT 10-K
NT 10-Q
PRE 14A
PRE 14C
PRER14A
PRER14C
RW
S-1
S-1/A
S-1MEF
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
Date
Form
Description
PDF
XBRL
Pages
11/14/18
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-10.1
EX-10.2
EX-31.1
EX-31.2
EX-32.1
72
11/14/18
8-K
Current report filing
3
11/13/18
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
4
11/08/18
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
11/05/18
8-K
Current report filing
Documents
EX-1.1
EX-4.1
EX-4.2
EX-4.3
EX-99.1
EX-99.2
101
10/31/18
424B4
Prospectus filed pursuant to Rule 424(b)(4)
34
10/30/18
S-1MEF
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
Documents
EX-5.1
EX-23.1
EX-23.2
10
10/29/18
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
10/29/18
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
10/29/18
EFFECT
Notice of Effectiveness
1
5
6
7
8
9
10
11
12
13
14
Home
About
Approach
Products
Investors
Blog
Contact